With new sharing options and low/high alerts on the horizon, the FreeStyle Libre just keeps getting better and better. Here are the pros and cons and info on how to get one.
read more →
Exciting new advances in glucagon delivery are right around the corner – injector pens, nasal sprays and mini-doses that can be self-administered.
read more →
The Sage Garden Project is an engaging program that brings gardens, cooking classes, and nutritional science to targeted public elementary schools throughout California with the goal of reducing the incidence of type 2 diabetes.
read more →
Primary Care Providers are responsible for about 90% of all diabetes care in the U.S. – the reality being there simply aren’t enough diabetes specialists or endocrinologists to go around. Open and honest communication between patient and provider lays the groundwork for long-term success in diabetes management.
read more →
Dr. Edelman’s 90-year-old mom (the short one) wrote this article with her friend Soni, who was diagnosed with type 2 diabetes later in life. Getting type 2 and taking control of it gave Soni new energy, new clothes and a new flame!
read more →
The newest classes of diabetes meds to treat type 2 are pulling more than double duty, helping to better control blood sugars, protect the heart, lower body weight and prevent chronic kidney disease.
read more →Evidence-based hope is letting people know that things are different than they were even 20 years ago. We now know that that with well-managed type 1 or type 2 diabetes, the odds are good you’re going to live a long and healthy life.
read more →
SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.
read more →
The use of DPP-4 inhibitors (Januvia, Onglyza, Tradjenta and Nesina) has been so widespread because these medications come in a pill, only need to be taken once a day and have few side effects.
read more →
Insulin sensitizers represent an important class of oral medications for the treatment of type 2 diabetes and work mainly by reducing insulin resistance, but a false scare with rosiglitatone led to prescribing changes for many healthcare providers.
read more →